Long-term Health Outcomes and Health System Costs Associated With Surgical Site Infections: A Retrospective Cohort Study.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 26 3 2019
medline: 25 5 2021
entrez: 26 3 2019
Statut: ppublish

Résumé

To examine the association between surgical site infections (SSIs) and hospital readmissions and all-cause mortality, and to estimate the attributable health care costs of SSIs 1 year following surgery. SSIs are a common postoperative complication; the long-term impact of SSI on health outcomes and costs has not been formally evaluated. This retrospective cohort study included all adult patients who underwent surgery at the 1202-bed teaching hospital in Ottawa, Ontario, Canada, and were included in the National Surgical Quality Improvement Program database between 2010 and 2015. The study exposure was postoperative SSI. The study outcomes included hospital readmission, all-cause mortality, and health care costs at 1 year (primary) and at 30 days and 90 days (secondary) following surgery. We identified 14,351 patients, including 795 patients with SSIs. Our multivariable analyses that accounted for competing risks demonstrated that at 1-year following the index date, superficial and deep/organ space SSIs were significantly associated with an increase in hospital readmission [hazard ratio (HR) = 1.63, 95% confidence interval (95% CI) 1.39-1.92 and HR = 3.49, (95% CI 2.76-4.17, respectively) and all-cause mortality (HR = 1.35, 95% CI 1.10-1.98 and HR = 2.21, 95% CI 1.44-2.78, respectively]. At 1 year after surgery, patients with superficial and deep/organ space SSIs incurred higher health care costs C$20,648 (95% CI) C$16,980- C$24,112and C$53,075 (95% CI) C$44,628- C$60,936), than non-SSI patients. SSIs, especially deep/organ space SSI, contribute to adverse health outcomes and health care costs across the entire year after surgery. Our findings highlight the importance of effective prevention/monitoring strategies targeting both short- and long-term consequences of SSI.

Sections du résumé

OBJECTIVES
To examine the association between surgical site infections (SSIs) and hospital readmissions and all-cause mortality, and to estimate the attributable health care costs of SSIs 1 year following surgery.
BACKGROUND
SSIs are a common postoperative complication; the long-term impact of SSI on health outcomes and costs has not been formally evaluated.
METHODS
This retrospective cohort study included all adult patients who underwent surgery at the 1202-bed teaching hospital in Ottawa, Ontario, Canada, and were included in the National Surgical Quality Improvement Program database between 2010 and 2015. The study exposure was postoperative SSI. The study outcomes included hospital readmission, all-cause mortality, and health care costs at 1 year (primary) and at 30 days and 90 days (secondary) following surgery.
RESULTS
We identified 14,351 patients, including 795 patients with SSIs. Our multivariable analyses that accounted for competing risks demonstrated that at 1-year following the index date, superficial and deep/organ space SSIs were significantly associated with an increase in hospital readmission [hazard ratio (HR) = 1.63, 95% confidence interval (95% CI) 1.39-1.92 and HR = 3.49, (95% CI 2.76-4.17, respectively) and all-cause mortality (HR = 1.35, 95% CI 1.10-1.98 and HR = 2.21, 95% CI 1.44-2.78, respectively]. At 1 year after surgery, patients with superficial and deep/organ space SSIs incurred higher health care costs C$20,648 (95% CI) C$16,980- C$24,112and C$53,075 (95% CI) C$44,628- C$60,936), than non-SSI patients.
CONCLUSION
SSIs, especially deep/organ space SSI, contribute to adverse health outcomes and health care costs across the entire year after surgery. Our findings highlight the importance of effective prevention/monitoring strategies targeting both short- and long-term consequences of SSI.

Identifiants

pubmed: 30907758
pii: 00000658-202105000-00014
doi: 10.1097/SLA.0000000000003285
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

917-923

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Ontario Research Fund (RE05-070) and Canadian Institutes of Health Research (CIHR) grant supported this study. The study design, opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No researcher involved in this study had any declared or otherwise known conflicts of interest. The authors report no conflicts of interest

Références

Gravel D, Taylor G, Ofner M, et al. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007; 66:243–248.
Malone DL, Genuit T, Tracy JK, et al. Surgical site infections: reanalysis of risk factors. J Surg Res 2002; 103:89–95.
NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. A report from the NNIS system. Am J Infect Control 1999; 27:520–532.
Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care associated infections. N Engl J Med 2014; 370:1198–1208.
European Centre for Disease Prevention and Control. Surveillance of Surgical Site Infections in Europe 2010-2011. Stockholm: ECDC; 2013. 2018.
Jenks PJ, Laurent M, McQuarry S, et al. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect 2014; 86:24–33.
Scott DR. “Direct Medical Costs of Healthcare-Associated Infections.” 2010, CDC. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf . Accessed May, 2017. 2010.
Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23:183–189.
Zoutman D, McDonald S, Vethanayagan D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol 1998; 19:254–259.
Badia JM, Casey AL, Petrosillo N, et al. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect 2017; 96:1–15.
Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005; 60:93–103.
Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725–730.
Lamarsalle L, Hunt B, Schauf M, et al. Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France. Epidemiol Infect 2013; 141:2473–2482.
Schweizer ML, Cullen JJ, Perencevich EN, et al. Costs associated with surgical site infections in veterans affairs hospitals. JAMA Surg 2014; 149:575–581.
Brown RB, Bradley S, Opitz E, et al. Surgical wound infections documented after hospital discharge. Am J Infect Control 1987; 15:54–58.
Sands K, Vineyerd G, Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis 1996; 173:963–970.
Cohen EM, Liu Y, Ko LC, et al. Improved surgical outcomes for ACS NSQIP hospitals over time: evaluation of hospital cohorts with up to 8 years of participation. Ann Surg 2016; 263:267–273.
Jones RS, Brown C, Opelka F. Surgeon compensation: “pay for performance”, the American College of Surgeons National Surgical Quality Improvement Program, the Surgical Care Improvement Program, and other considerations. Surgery 2005; 138:829–836.
Centers for Disease Control and Prevention. National Healthcare Safety Network: Surgical Site Infection (SSI) Event. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf . Accessed May 12, 2017. 2010. In press.
Bagnall NM, Vig S, Triverdi P. Surgical-site infection. Surgery (Oxford) 2009; 27:426–430.
Shiloach M, Frencher S, Steeger J, et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2010; 1:6–16.
Wodchis WP, Bushmeneva K, Nikitovic M, McKillop I. Guidelines on Person Level Costing Using Administrative Databases in Ontario. Working Paper Series. Vol 1. Toronto: Health System Performance Research Network; 2013.
Ontario Ministry of Health and Long Term Care. Schedule of Benefits for Physician Services: Consultations and Visits. 2014. Available at: http://www.health.gov.on.ca/english/providers/program/ohip/sob/physserv/a_consul.pdf . 2017. Accessed May 15, 2017.
Canadian Institute for Health Information. CCRS Technical Document-Ontario RUG Weighted Patient Day. Ottawa: Canadian Institute for Health Information; 2014, 2017.
Daabiss M. American Society of Anaesthesiologists physical status classification. Indian J Anaesth 2011; 55:111–115.
van Walraven C, ong J, Bennett C, et al. The Procedural Index for Mortality Risk (PIMR): an index calculated using administrative data to quantify the independent influence of procedures on risk of hospital death. BMC Health Serv Res 2011; 11:258.
Matheson FI, Dunn JR, Smith KLW, et al. Development of the Canadian marginalization index: a new tool for the study of inequality. Can J Public Health 2012; 103: (8 suppl 2): S12–S16.
Johns Hopkins Bloomberg School of Public Health. The Johns Hopkins ACG© Case-Mix System Version 8.2. Baltimore, MD: Johns Hopkins Bloomberg School of Public Health; 2008, 2017. In press.
Etzioni R, Riley GF, Ramsey SD. Measuring costs: administrative claims data, clinical trials, and beyond. Med Care 2002; 40: (6 suppl): III63–III72.
Shepard J, Ward W, Milstone A. Financial impact of surgical site infections on hospitals: the hospital management perspective. JAMA Surg 2013; 148:907–914.
Boltz MM, Hollenbeak CS, Julian KG, et al. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery 2011; 150:934–942.
Alfonso JL, Pereperez SB, Canoves JM, et al. Are we really seeing the total costs of surgical site infections? A Spanish study. Wound Repair Regen 2007; 15:474–481.
Lankiewicz JD, Yokoe DS, Olsen MA, et al. Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection? Infect Control Hosp Epidemiol 2012; 33:202–204.
Wijeratna MD, McRoberts J, Porteous MJ. Cost of infection after surgery for intracapsular fracture of the femoral neck. Ann R Coll Surg Engl 2015; 97:283–286.

Auteurs

Yelena Petrosyan (Y)

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Kednapa Thavorn (K)

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Institute for Clinical and Evaluative Sciences (ICES uOttawa), Ottawa, Ontario, Canada.

Malcolm Maclure (M)

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

Glenys Smith (G)

Institute for Clinical and Evaluative Sciences (ICES uOttawa), Ottawa, Ontario, Canada.

Daniel I McIsaac (DI)

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Institute for Clinical and Evaluative Sciences (ICES uOttawa), Ottawa, Ontario, Canada.
Department of Anesthesiology & Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada.

David Schramm (D)

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Otolaryngology/Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada.

Husein Moloo (H)

Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada.

Roanne Preston (R)

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

Alan J Forster (AJ)

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Institute for Clinical and Evaluative Sciences (ICES uOttawa), Ottawa, Ontario, Canada.
Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH